Team Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7
Closed -$6.44K 168
2026
Q1
$6.44K Sell
7
-41
-85% -$41.6K ﹤0.01% 209
2025
Q4
$51.3K Hold
48
0.02% 103
2025
Q3
$36.4K Hold
48
0.02% 113
2025
Q2
$37.1K Buy
+48
New +$37.3K 0.02% 105
2024
Q1
Sell
-40
Closed -$23.4K 133
2023
Q4
$23.4K Hold
40
0.02% 90
2023
Q3
$21.5K Buy
+40
New +$20.6K 0.02% 90

Other funds holding LLY

Team Financial Group's LLY Position: Q2 2026 in Review

Team Financial Group sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 7 shares — an estimated $6.44K sold.

Team Financial Group first reported a position in LLY in Q3 2023 and held it in 6 quarters. The position peaked at $51.3K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Team Financial Group reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Team Financial Group sold 7 Eli Lilly shares in Q2 2026, an estimated $6.44K.
  • Team Financial Group first reported a position in Eli Lilly in Q3 2023 and held it in 6 quarters.
  • Team Financial Group's Eli Lilly position peaked at $51.3K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Team Financial Group's 13F filing for Q2 2026, filed 13 Jul 2026.